Dangerous Drugs Torrance
Personal Injury Lawyers Near Torrance For Dangerous Drugs
Written by Daniel Benji, Esq. head attorney of Benji Personal Injury Accident Attorneys A.P.C.
Residents of Torrance rely on prescription and over-the-counter medications to manage health conditions and improve their quality of life. While strict regulations govern the pharmaceutical industry, dangerous drugs still reach the marketplace and cause severe injury or death. When a medication causes harm due to defects or inadequate warnings, victims have the right to seek legal recourse under California product liability laws.
Benji Personal Injury Accident Attorneys represents individuals and families in Torrance and the greater South Bay area who have suffered adverse health effects from dangerous medications. Understanding the specific legal grounds for these claims helps injured parties determine their next steps.
Liability in Pharmaceutical Litigation
Dangerous drug cases in California typically fall under the umbrella of product liability. Unlike standard personal injury cases that often require proof of negligence, many pharmaceutical claims operate under the doctrine of strict liability. This means a manufacturer may be held responsible for damages caused by a defective product regardless of whether they acted negligently during the production process. For certain claims, such as failure to warn, strict liability applies when the risks were known or knowable through scientific and medical knowledge at the time of manufacture or distribution.
Liability generally extends to three primary parties:
- Pharmaceutical Manufacturers: The companies responsible for developing, testing, producing, and marketing the drug.
- Prescribing Physicians: Doctors may face liability if they prescribe the wrong dosage, ignore known drug interactions, or fail to consider a patient's medical history.
- Pharmacists: Liability may arise if a pharmacist dispenses the incorrect medication or dosage.
Types of Defect Claims
To succeed in a lawsuit against a pharmaceutical manufacturer, a plaintiff generally must prove that the drug was defective. California law recognizes distinct categories of defects in these cases.
Manufacturing Defects
A manufacturing defect occurs when a specific batch or lot of a drug departs from its intended design. This often results from errors during the production process, such as contamination or incorrect formulation. In these instances, the drug differs from the manufacturer's own specifications.
Failure to Warn
The majority of pharmaceutical litigation involves failure to warn claims. Manufacturers possess a duty to disclose all known or scientifically knowable risks associated with their medications. If a company fails to provide adequate warnings to medical providers or consumers regarding side effects, they may be liable for resulting injuries.
Under the "Learned Intermediary Doctrine," manufacturers discharge their duty to warn by providing adequate information to the prescribing physician rather than the patient directly. The physician then assumes the responsibility of assessing the risks and benefits for the patient.
Key California Legal Precedents
Litigation regarding dangerous drugs in Torrance is shaped by specific California Supreme Court decisions. These cases establish the framework for how liability is determined and what plaintiffs must prove.
| Case Name | Legal Principle Established |
|---|---|
| Greenman v. Yuba Power Products, Inc. (1963) | This case established the doctrine of Strict Product Liability in California. It allows plaintiffs to hold manufacturers liable for defective products without proving negligence. |
| Brown v. Superior Court (1988) | The court ruled that manufacturers are generally not strictly liable for design defects in prescription drugs if the drug was properly prepared and accompanied by adequate warnings. This effectively focuses most drug litigation on "failure to warn" or "manufacturing defect" theories for prescription pharmaceuticals. |
| Himes v. Somatics, LLC (2024) | This recent ruling clarified causation in failure-to-warn cases under the learned intermediary doctrine. It established that a plaintiff is not required to prove a stronger warning would have altered the physician's decision to prescribe the drug. Instead, a plaintiff may establish causation by demonstrating that the physician would have relayed the more robust warning to the patient, and that an objectively prudent person in the patient's position would have then declined the treatment. |
Commonly Litigated Dangerous Drugs
Pharmaceutical litigation often involves medications that have been on the market for years before serious side effects are fully understood or disclosed. Benji Personal Injury Accident Attorneys monitors developments regarding various classes of drugs.
- Opioids: Prescription painkillers such as OxyContin and Fentanyl are frequently cited in litigation regarding addiction, overdose, and death.
- Blood Thinners: Anticoagulants like Xarelto and Pradaxa have been linked to uncontrollable internal bleeding and stroke events.
- Diabetes Medications: Drugs including Invokana and Ozempic face scrutiny regarding side effects such as kidney failure, ketoacidosis, and circulatory issues leading to amputation.
- Heartburn Medications: Proton pump inhibitors like Zantac, Prilosec, and Nexium have been the subject of lawsuits involving cancer risks and kidney disease.
Statute of Limitations in California
Time is a critical factor in dangerous drug claims. In California, the statute of limitations for personal injury cases is generally two years from the date the injury occurred.
However, the "discovery rule" may apply in pharmaceutical cases. This rule delays the start of the statute of limitations until the plaintiff discovers, or reasonably should have discovered, that their injury was caused by the drug. Given the complex nature of medical injuries and the latency of some drug-related side effects, determining the exact deadline for filing a claim requires careful legal analysis by an experienced attorney.
Torrance and Los Angeles County Jurisdiction
Legal actions originating in Torrance fall under the jurisdiction of the Superior Court of California, County of Los Angeles. Dangerous drug cases are often classified as complex litigation due to the scientific evidence and expert testimony involved, frequently requiring specialized handling within the Los Angeles Superior Court system.
Residents in the South Bay, including Torrance, utilize regional healthcare providers and national pharmacy chains. Consequently, they are subject to the same risks from the global pharmaceutical supply chain as patients throughout the state. Legal claims arising here are processed within the Los Angeles legal system, adhering to the precedents set by California appellate courts.
Benji Personal Injury Accident Attorneys manages the procedural requirements of filing and litigating these claims within the local court system, ensuring that all evidence and documentation meet the rigorous standards required by state law.
By submitting this form, you agree to our Terms of Service and acknowledge our Privacy Policy. You also consent to receive calls, texts and emails from Benji Personal Injury Accident Attorneys.